In contrast, compared with that in the pretreatment group, the expression level of IL-6 in the LHQW treatment group was not significantly greater, which is consistent with the findings of Shen et al., who reported that LHQW had no inhibitory effect on IL-6 expression in COVID-19 patients (Shen et al., 2021). Here, IL6 is linked to COVID-19.